🍪 Cookies
We use analytics cookies (Google Analytics) to understand how you use the site. You can accept or reject them — the site works fully either way.
Neurodegenerative diseases such as Alzheimer's Disease are devastating conditions that impact millions globally. These diseases are driven by the misfolding and aggregation of proteins, which lead to brain cell death and cognitive decline. To make matters worse, as we age our cells become more error-prone, resulting in more errors during protein printing, causing proteins to clump together and form aggregates. Project Transfidelity aims to solve this by improving the accuracy of protein printing, preventing toxic aggregates from forming. Led by Dr. Dimitri Scherbakov and Dr. Rashid Akbergenov, with over 50 years of combined experience in the lab, we have identified two molecules that may improve the efficiency of protein production, potentially preventing protein aggregates, hypothesized to cause dementia. Despite the significant research funding allocated to neurodegenerative diseases, current therapies continue to treat the symptoms caused by the protein aggregates, with little progr
Transfidelity (FIDEL) is a cryptocurrency that can be traded on various exchanges. It has a current market capitalization of $83,279, making it one of the notable digital assets in the crypto market.
The current price of Transfidelity (FIDEL) is $0.0833. Prices update in real-time based on market activity across major cryptocurrency exchanges.
You can buy Transfidelity (FIDEL) on major cryptocurrency exchanges such as Binance, Coinbase, and Kraken. Always use a reputable exchange and enable two-factor authentication to secure your account.
Whether Transfidelity is a good investment depends on your financial goals, risk tolerance, and research. Cryptocurrency markets are highly volatile. Always do your own research and consider consulting a financial advisor before investing.
Top cryptocurrencies with market capitalization closest to this coin.